Apellis Pharmaceuticals (NASDAQ:APLS – Get Rating) had its price objective hoisted by Wells Fargo & Company from $55.00 to $76.00 in a research note issued to investors on Friday, The Fly reports. Wells Fargo & Company‘s target price would suggest a potential downside of 9.92% from the company’s previous close. Several other equities analysts also […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating)’s share price traded down 6.1% during mid-day trading on Thursday . The stock traded as low as $78.14 and last traded at $79.55. 898,539 shares changed hands during trading, a decline of 47% from the average session volume of 1,702,431 shares. The stock had previously closed at $84.68. […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating) shares traded down 6.1% on Thursday . The company traded as low as $78.14 and last traded at $79.55. 898,539 shares were traded during trading, a decline of 47% from the average session volume of 1,702,431 shares. The stock had previously closed at $84.68. Analyst Upgrades and Downgrades […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Rating)’s stock price hit a new 52-week high during mid-day trading on Monday . The company traded as high as $88.51 and last traded at $88.27, with a volume of 1040253 shares traded. The stock had previously closed at $86.25. Analyst Ratings Changes A number of research analysts have […]
Should You Buy or Sell Apellis Pharmaceuticals Stock? Get The Latest APLS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.